Has Michelle Bowman, MD received payments from drug or device companies?

Yes. Drug and device makers reported $418,658 in general payments to Michelle Bowman, MD across 602 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michelle Bowman, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michelle Bowman, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michelle Bowman, MD

Neurology · Cincinnati, OHNPI 1699094532

Payments from drug & device makers

$418,658in general payments, 2019–2025

Across 602 payments — averaging $695.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Roche Products Limited$164K
Sanofi$96K
Biogen$52K
Novartis$39K
TG Therapeutics, Inc.$30K
Genentech USA, Inc.$14K
plus $25K from 41 others

$2,796in research payments, 2019–2025

Across 24 payments — averaging $116.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Sanofi US Services Inc.$2K
EMD Serono, Inc.$1K

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Roche Products Limited	305	$163,978
Sanofi	50	$95,624
Biogen	52	$51,507
Novartis	63	$38,857
TG Therapeutics, Inc.	11	$30,438
Genentech USA, Inc.	15	$13,610
Janssen Research & Development, LLC	2	$11,950
EMD Serono, Inc.	11	$6,376
Janssen Global Services, LLC	4	$3,869
AbbVie(2 entities)	14	$288
AstraZeneca	8	$219
Sanofi-aventis U.S. LLC	2	$192
Bristol Myers Squibb	4	$167
Genentech, Inc.	3	$161
Johnson & Johnson(2 entities)	2	$157
Amgen(2 entities)	3	$153
E.r. Squibb & Sons, L.L.C.	1	$117
Teva Pharmaceuticals USA, Inc.	7	$111
Pfizer	4	$92
Medtronic	2	$60
Lundbeck LLC	2	$54
Lilly USA, LLC	3	$51
MDD US Operations, LLC	2	$46
Upsher-smith Laboratories LLC	2	$46
Neurelis, Inc.	2	$43
Acadia Pharmaceuticals Inc	2	$42
Mallinckrodt Enterprises LLC	2	$40
UCB, Inc.	2	$39
Boston Scientific	2	$34
Grifols USA, LLC	2	$29
Vanda Pharmaceuticals Inc.	1	$27
Acorda Therapeutics, Inc	2	$26
Averitas Pharma Inc.	1	$23
Neurocrine Biosciences, Inc.	1	$22
Amneal Pharmaceuticals LLC	1	$22
Axsome Therapeutics, Inc.	1	$21
Eisai Inc.	1	$21
Livanova USA, Inc.	1	$20
Merz Pharmaceuticals, LLC	1	$19
Takeda Pharmaceuticals U.S.A., Inc.	1	$17
Tanabe Pharma America, Inc.	1	$16
Scilex Pharmaceuticals Inc.	1	$15
Aquestive Therapeutics, Inc.	1	$14
Azurity Pharmaceuticals, Inc.	1	$14
Aprecia Pharmaceuticals, LLC	1	$12
CSL Behring	1	$12
Daxor Corporation	1	$8

How this compares

$418,658 in reported general payments places this provider in the 90th percentile of 702 neurology providers in Ohio.

See all neurology providers in Ohio →

Medicare billing

Part B allowed, 2024

$1,736,219

Medicare patients

194

Services billed

38,686

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Cincinnati

Aram ZabetiCincinnati$5.3M
Hani KushlafCincinnati$1.9M
Alberto EspayCincinnati$785K
Brandon ForemanCincinnati$677K
Andrew DukerCincinnati$620K
Joel VandersluisDayton$12.3M
Jerry MendellColumbus$11.5M
Lawrence GoldstickDayton$6.9M
Douglas ScharreColumbus$6.8M
Robert BermelCleveland$6.4M

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →